Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell envelope and core cellular processes encompass the fundamental structural components and metabolic pathways required for bacterial survival and replication. The cell envelope, consisting of the plasma membrane and the peptidoglycan cell wall, maintains cellular integrity and regulates the transport of nutrients and waste (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). Core cellular processes include DNA replication, RNA transcription, and protein synthesis, which are executed by highly conserved molecular machinery such as DNA gyrase, RNA polymerase, and ribosomes (Kohanski et al., 2010, Nat Rev Microbiol). These systems are the primary targets for the majority of clinically used antibiotics, which exploit the structural and functional differences between prokaryotic and eukaryotic cells to achieve selective toxicity. For instance, beta-lactam antibiotics inhibit cell wall synthesis, while aminoglycosides and macrolides interfere with ribosomal function to halt protein production (Walsh, 2003, Antibiotics: Actions, Origins, Resistance). Disruption of these essential pathways leads to bacteriostatic or bactericidal effects, making them critical for the treatment of diverse bacterial infections. However, the emergence of antimicrobial resistance mechanisms, such as target modification or efflux pumps, poses a significant challenge to the continued efficacy of drugs hitting these targets.
Inhibition of peptidoglycan cross-linking, inhibition of protein synthesis via ribosomal binding, inhibition of DNA topoisomerases, and inhibition of RNA polymerase.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell envelope and core cellular processes.